Global Bio-chem Technology's (HKG:0809) attributable profit fell to HK$769.6 million in 2024 from HK$4.22 billion in 2023, according to an annual report filed Wednesday with the Hong Kong bourse.
Earnings per share at the biotechnology firm increased to HK$0.029 from HK$0.291 in the previous year.
Revenue grew to HK$2 billion from HK$1.37 billion a year earlier.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.